You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
|
|---|---|
| Published in |
Frontiers in endocrinology, June 2023
|
| DOI | 10.3389/fendo.2023.1211473 |
| Pubmed ID | |
| Authors |
Anne Gulbins, Mareike Horstmann, Anke Daser, Ulrich Flögel, Michael Oeverhaus, Nikolaos E. Bechrakis, J. Paul Banga, Simone Keitsch, Barbara Wilker, Gerd Krause, Gary D. Hammer, Andrew G. Spencer, Ryan Zeidan, Anja Eckstein, Svenja Philipp, Gina-Eva Görtz |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 17% |
| Unknown | 5 | 83% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 15 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 2 | 13% |
| Student > Bachelor | 1 | 7% |
| Student > Doctoral Student | 1 | 7% |
| Student > Ph. D. Student | 1 | 7% |
| Researcher | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 9 | 60% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
| Business, Management and Accounting | 1 | 7% |
| Mathematics | 1 | 7% |
| Unknown | 10 | 67% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2024.
All research outputs
#14,907,525
of 26,180,352 outputs
Outputs from Frontiers in endocrinology
#2,947
of 13,379 outputs
Outputs of similar age
#152,763
of 383,628 outputs
Outputs of similar age from Frontiers in endocrinology
#107
of 785 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,379 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 383,628 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 785 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.